可重新填充的式,具有精确切换,用于定时的治疗输送
Naaz Thotathil1, John J Amante1, Micah Wingell1
1Kearney Lab, Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA, United States.
Frontiers in bioengineering and biotechnology
|September 29, 2025
概括
这项研究介绍了一种新的软机器人药物输送,用于精确,定时的治疗管理. 该设备提供可靠的开/关控制,并成功地提供各种疗法,提高药物输送效率.
科学领域:
- 生物医学工程 生物医学工程
- 机器人技术 机器人技术 机器人技术
- 药物输送系统 药物输送系统
背景情况:
- 精确的生物过程的时间控制提高了治疗疗效.
- 目前的刺激响应药物递送方法面临着诸如过早泄漏和不一致的响应等局限性.
- 需要先进的药物输送系统,以改善治疗结果.
研究的目的:
- 引入一种柔软的机器人压力驱动药物输送,用于准确定时的治疗施用.
- 克服现有的药物输送技术的局限性,提高治疗疗效.
- 为了证明该设备的可控和重复的药物输送能力.
主要方法:
- 开发了一个软的机器人,使用来实现生物相容,可符合的接口.
- 在执行室内内置的可充电端口用于持续使用.
- 测试了压力依赖释放,重复释放,基线释放和各种治疗药物的输送 (28.5 - 59.8 mmHg).
主要成果:
- 在5天内展示了可靠的开/关机制,解决了当前技术的关键局限性.
- 在体外成功输送了一系列治疗药物,包括抗生素,腺相关病毒 (AAV),德克萨米他和活细胞,其疗效与手动输送相美.
- 开发了一个有限元模型来分析压力/体积释放趋势和膜刚性的影响.
结论:
- 开发的软型机器人使得各种疗法可以在保持生物活性的同时进行一致和精确的时间管理.
- 该设备显示出重复治疗应用的巨大潜力.
- 这项技术为先进的,可控的药物输送系统提供了一个有前途的解决方案.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
01:23Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
01:26Oral Drug Delivery Systems: Continuous-Release Systems
319
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
319
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
211
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
211